Quick Answer
NEKTAR THERAPEUTICS reported Earnings Per Share Diluted of $9.73 (loss) per share for the year ending 2025.
- NEKTAR THERAPEUTICS showed a decrease of -12.1% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from NEKTAR THERAPEUTICS's annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: $0.14 (loss) per share | Q1 2014: $0.37 (loss) per share | Q3 2014: $0.53 per share | Q1 2015: $0.25 per share | Q3 2015: $0.06 (loss) per share | Q1 2016: $0.14 (loss) per share | Q3 2016: $0.32 (loss) per share | Q1 2017: $0.42 (loss) per share | Q2 2017: $0.39 (loss) per share | Q3 2017: $0.37 per share | Q4 2017: $0.21 (loss) per share | Q1 2018: $0.60 (loss) per share | Q2 2018: $5.33 per share | Q3 2018: $0.56 (loss) per share | Q4 2018: $0.57 (loss) per share | Q1 2019: $0.69 (loss) per share | Q2 2019: $0.63 (loss) per share | Q3 2019: $0.56 (loss) per share | Q4 2019: $0.64 (loss) per share | Q1 2020: $0.78 (loss) per share | Q2 2020: $0.45 (loss) per share | Q3 2020: $0.61 (loss) per share | Q4 2020: $0.65 (loss) per share | Q1 2021: $0.68 (loss) per share | Q2 2021: $0.69 (loss) per share | Q3 2021: $0.70 (loss) per share | Q4 2021: $790.00 (loss) per share | Q1 2022: $0.49 (loss) per share | Q2 2022: $0.85 (loss) per share | Q3 2022: $0.31 (loss) per share | Q1 2023: $0.73 (loss) per share | Q2 2023: $0.27 (loss) per share | Q3 2023: $0.24 (loss) per share | Q1 2024: $0.19 (loss) per share | Q2 2024: $3.76 (loss) per share | Q3 2024: $2.66 (loss) per share | Q1 2025: $0.24 (loss) per share | Q2 2025: $2.95 (loss) per share | Q3 2025: $1.87 (loss) per share.
- Over the full 10 years of available data (2016 to 2025), NEKTAR THERAPEUTICS's Earnings Per Share Diluted has declined by 784.5%.
- Historical annual values: Fiscal year 2025: $9.73 (loss) per share | Fiscal year 2024: $8.68 (loss) per share | Fiscal year 2023: $1.45 (loss) per share | Fiscal year 2022: $1.97 (loss) per share | Fiscal year 2021: $2.86 (loss) per share | Fiscal year 2020: $2.49 (loss) per share | Fiscal year 2019: $2.52 (loss) per share | Fiscal year 2018: $3.78 per share | Fiscal year 2017: $0.62 (loss) per share | Fiscal year 2016: $1.10 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: